Exact Sciences Corporation (EXAS) Sets New 52-Week High Following Earnings Beat

Exact Sciences Corporation (NASDAQ:EXAS) reported its EPS in the last quarter as $-0.23/Share beating the analyst estimate of $-0.3/Share by a difference of $0.07. In a research report issued to clients and investors on 31 October, EXACT Sciences (NDAQ:EXAS) shares have had their "Buy" Rating restate by research analysts at Benchmark.

Hedge funds have recently modified their holdings of the stock. Ameritas Investment Partners Inc. increased its position in shares of Exact Sciences Corporation by 5.6% in the second quarter. EXACT Sciences Corporation (NASDAQ:EXAS) has risen 458.24% since November 1, 2016 and is uptrending. Federated Investors Inc. PA now owns 34,553 shares of the medical research company's stock worth $1,222,000 after buying an additional 12,018 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of Exact Sciences Corporation by 17.3% in the second quarter. Prudential Financial Inc. now owns 11,141 shares of the medical research company's stock worth $263,000 after acquiring an additional 320 shares in the last quarter. For the week, the stock is performing 1.97%.

Exact Sciences Corporation (NASDAQ:EXAS) belongs to Healthcare sector, the firm standing on a contradictory position. The stock was sold at an average price of $47.16, for a total transaction of $1,373,063.40. Following the completion of the purchase, the director now owns 60,858 shares in the company, valued at $2,294,955.18. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. The stock was sold at an average price of $40.81, for a total value of $3,088,623.23. Following the sale, the insider now owns 308,377 shares in the company, valued at $12,584,865.37. The disclosure for this purchase can be found here.

The company now has an insider ownership of 2.1 Percent and Institutional ownership of 87.4 Percent. Corporate insiders own 4.00% of the company's stock. Qs Investors Ltd Limited Liability Company has 0% invested in EXACT Sciences Corporation (NASDAQ:EXAS) for 2,518 shares. According to today's trading volume Exact Sciences Corporation is ABOVE its 20-Day Avg. volume with the stock showing ABOVE Abnormal volume in the past 150 days. Exact Sciences Corporation has a 1-year low of $13.05 and a 1-year high of $57.95. The Firm has ATR of 1.99 that is explaining range of a day's trading is high-low; ATR expands it to yesterday's closing price if it was outside of current range.

Exact Sciences Corporation (NASDAQ:EXAS) last posted its quarterly earnings data on Monday, October 30th. The stock of EXACT Sciences Corporation (NASDAQ:EXAS) earned "Buy" rating by TH Capital on Wednesday, February 22. The company had revenue of $72.60 million for the quarter, compared to analyst estimates of $65.03 million.

Analysts have a mean recommendation of 2.30 on this stock (A rating of less than 2 means buy, "hold" within the 3 range, "sell" within the 4 range, and "strong sell" within the 5 range).

09/21/2017 - EXACT Sciences Corporation had its "outperform" rating reiterated by analysts at Leerink Swann. Finally, Canaccord Genuity upgraded Exact Sciences Corporation to a "buy" rating and set a $60.00 target price on the stock in a research report on Tuesday. Craig Hallum increased their target price on Exact Sciences Corporation from $46.00 to $61.00 and gave the stock a "buy" rating in a research report on Tuesday. Five research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the stock. The stock has a consensus rating of "Buy" and an average price target of $49.71.

COPYRIGHT VIOLATION WARNING: "Horseman Capital Management Ltd Takes Position in Exact Sciences Corporation (EXAS)" was originally reported by Week Herald and is the property of of Week Herald. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States & global trademark and copyright legislation. The correct version of this piece can be read at

EXACT Sciences Corporation uses applied genomics to develop effective, patient-friendly screening technologies for use in the detection of cancer. The Firm focuses on the early detection and prevention of some forms of cancer. Certain of its technologies have been licensed to Laboratory Corporation of America Holdings for a stool-based DNA screening assay for colorectal cancer in the average-risk population.

Like this



01 November 2017
SodaStream International Ltd. (SODA) Issues FY17 Earnings Guidance
Eqis Capital Management Inc. increased its stake in shares of SodaStream International by 0.6% in the third quarter. Four research analysts have rated the stock with a hold rating and four have issued a buy rating to the company.

01 November 2017
Canaccord Genuity Raises Franco Nevada Corp (FNV) Price Target to C$119.00
It is highly important for investors to understand exactly what risks they are taking when buying and selling stocks. The value of the investment in FNV increased from $1,467,000 to $1,530,000 a change of $63,000 quarter over quarter.

01 November 2017
17-year-old Prithvi Shaw scores fourth century in five First-class matches
Before that, the opening batsman hit 154 off 249 balls for India Red in their Duleep Trophy match against India Blue at Lucknow. Shaw now has 552 First-class runs at an average of 69 with four hundreds and a fifty.

01 November 2017
Hard Facts About Tanger Factory Outlet Centers Inc. (NYSE:SKT)
First Trust Advisors Lp expanded its ownership by buying 314,182 shares an increase of 204.3% from 06/30/2017 to 09/30/2017. Sanders Morris Harris Inc. boosted its stake in shares of Tanger Factory Outlet Centers by 0.9% in the second quarter.

01 November 2017
ACLU suing for release of 10-year-old immigrant with cerebral palsy
Alina Das of the New York University School of Law and Ranjana Natarajan of the University of Texas School of Law are co-counsel. The government's actions are unlawful, cruel, and threaten to keep parents with sick children from seeking care.

01 November 2017
Envision Healthcare Corp. (EVHC) Is Sinking After Q3 Profit Drops
LMR Partners LLP bought a new stake in shares of Envision Healthcare Corporation during the 2nd quarter valued at about $205,000. This repurchase authorization authorizes the company to repurchase up to 4.5% of its shares through open market purchases.

01 November 2017
Sinclair Broadcast reports drop in sales and profits for third quarter
The deal could give Sinclair control of 233 television stations that reach 72 percent of USA households. On a per-share basis, the Hunt Valley, Maryland-based company said it had profit of 30 cents.

01 November 2017
Google Pixel 2 now available in India
The main highlight of Pixel 2 is its camera, DxOMark Mobile has given the highest rating to second-gen Pixel smartphone. Following the trend, Google has also ditched the 3.5mm audio-jack and the audio is routed through a headphone adaptor.

01 November 2017
Earnings Forecast of Western Digital Corporation (WDC)
Harbour Capital Advisors LLC acquired a new position in Western Digital Corp in the first quarter valued at about $117,000. Regentatlantic Capital Ltd Limited Liability Company invested 0.31% of its portfolio in Western Digital Corp (NASDAQ:WDC).

01 November 2017
IBM unveils software that brings public cloud to private datacenters
The "Security Vulnerability Advisor" scans containers across the cloud to surface potentially serious issues and weaknesses. That's particularly important for customers who have legacy workloads and want to move them to a more modern platform.